You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美國醫療保險和醫療補助服務中心:限制為百健公司(BIIB.US)老年痴呆症藥物Aduhelm付款
格隆匯4月8日丨美國醫療保險和醫療補助服務中心週四證實,將只為參加已批准的臨牀試驗的病人支付百健公司(BIIB.US)的老年痴呆症藥物Aduhelm。Aduhelm是唯一獲得美國食品和藥物管理局批准的該類藥物。華爾街日報報道稱,這將大大減少能夠服用Aduhelm的患者數量,同時也限制了其商業潛力。雖然本次只有百健公司受到影響,但這一決定也可能給禮來(LLY.US)和羅氏(RHHBY.US)正在開發的類似藥物帶來影響。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account